PharmaPrint Inc.:
- Share via
The Irvine manufacturer of dietary supplements, foods and pharmaceuticals said it lost $7.4 million, or 53 cents a share, for its fiscal third quarter, contrasted with net income of $2.7 million, or 18 cents a share, for the like period a year ago. Revenue for the quarter ended Dec. 31 dropped to $493,476 from $11.9 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
